Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease

Haematologica

Volumn 102, Issue 5, 2017, Pages e210-e213

  Spindelboeck, Walter ^a   Schulz, Eduard ^a   Uhl, Barbara ^a   Kashofer, Karl ^a   Aigelsreiter, Ariane ^a   Zinke Cerwenka, Wilma ^a   Mulabecirovic, Adnan ^a   Kump, Patrizia K ^a   Halwachs, Bettina ^a   Gorkiewicz, Gregor ^a   Sill, Heinz ^a   Greinix, Hildegard ^a   Högenauer, Christoph ^a   Neumeister, Peter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b BIOTECHMED GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CYCLOSPORIN A; ETANERCEPT; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; MELPHALAN; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; RAPAMYCIN; RNA 16S; RUXOLITINIB;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE MYELOID LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APOPTOSIS; BRAIN INFARCTION; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; CAUSE OF DEATH; COLONOSCOPY; DIARRHEA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENDOSCOPY; ESCHERICHIA COLI; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; FEMALE; GASTROINTESTINAL DISEASE; GENETIC ANALYSIS; HISTOLOGY; HUMAN; ILEITIS; IMMUNOSUPPRESSIVE TREATMENT; KLEBSIELLA PNEUMONIAE; LETTER; MALE; MENINGITIS; MIDDLE AGED; OUTCOME ASSESSMENT; PHOTOPHERESIS; REFRACTORY ANEMIA WITH EXCESS BLASTS; SEPTICEMIA; SPECIES RICHNESS; TOTAL PARENTERAL NUTRITION; FECES; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MICROBIOLOGY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; DIARRHEA; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; GASTROINTESTINAL DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 85018972318     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2016.154351     Document Type: Letter

References (16)

1. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373(9674):1550-1561.
2. MacMillan ML, DeFor TE, Weisdorf DJ. What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score. Br J Haematol. 2012;157(6):732-741.
3. Martin PJ, Rizzo JD, Wingard JR, et al. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2012;18(8):1150-1163.
4. Castilla-Llorente C, Martin PJ, McDonald GB, et al. Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2014; 49(7):966-971.
5. Wolff D, Ayuk F, Elmaagacli A, et al. Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers. Biol Blood Marrow Transplant. 2013;19(5):767-776.
6. Jenq RR, Ubeda C, Taur Y, et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med. 2012;209(5):903-911.
7. Holler E, Butzhammer P, Schmid K, et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20(5):640-645.
8. Mathewson ND, Jenq R, Mathew AV, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016;17(5):505-513.
9. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013; 368(5):407-415.
10. Song Y, Garg S, Girotra M, et al. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS One. 2013;8(11):e81330.
11. Webb BJ, Brunner A, Ford CD, et al. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2016;18(4):628-633.
12. Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109(7):1065-1071.
13. Kakihana K, Fujioka Y, Suda W, et al. Fecal microbiota transplantation for patients with steroid-resistant/dependent acute graft-versus-host disease of the gut. Blood. 2016 Jul 26. [Epub ahead of print]
14. Shono Y, Docampo MD, Peled JU, et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med. 2016;8(339):339ra371.
15. Young JA, Logan BR, Wu J, et al. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors. Biol Blood Marrow Transplant. 2016;22(2):359-370.
16. Ramaprasad C, Pursell KJ. Infectious complications of stem cell transplantation. Cancer Treat Res. 2014;161:351-370.